BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 16888100)

  • 1. STAT3 governs distinct pathways in emergency granulopoiesis and mature neutrophils.
    Panopoulos AD; Zhang L; Snow JW; Jones DM; Smith AM; El Kasmi KC; Liu F; Goldsmith MA; Link DC; Murray PJ; Watowich SS
    Blood; 2006 Dec; 108(12):3682-90. PubMed ID: 16888100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOCS3 is a physiological negative regulator for granulopoiesis and granulocyte colony-stimulating factor receptor signaling.
    Kimura A; Kinjyo I; Matsumura Y; Mori H; Mashima R; Harada M; Chien KR; Yasukawa H; Yoshimura A
    J Biol Chem; 2004 Feb; 279(8):6905-10. PubMed ID: 14699146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MST1 controls murine neutrophil homeostasis
    Masgrau-Alsina S; Wackerbarth LM; Lim DS; Sperandio M
    Front Immunol; 2022; 13():1038936. PubMed ID: 36618429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation.
    Lee CK; Raz R; Gimeno R; Gertner R; Wistinghausen B; Takeshita K; DePinho RA; Levy DE
    Immunity; 2002 Jul; 17(1):63-72. PubMed ID: 12150892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The RNA m
    Liu Y; Song R; Lu Z; Zhao L; Zhan X; Li Y; Cao X
    Cell Mol Immunol; 2024 Jan; 21(1):6-18. PubMed ID: 38114747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT3 controls the neutrophil migratory response to CXCR2 ligands by direct activation of G-CSF-induced CXCR2 expression and via modulation of CXCR2 signal transduction.
    Nguyen-Jackson H; Panopoulos AD; Zhang H; Li HS; Watowich SS
    Blood; 2010 Apr; 115(16):3354-63. PubMed ID: 20185584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Src family kinases are important negative regulators of G-CSF-dependent granulopoiesis.
    Mermel CH; McLemore ML; Liu F; Pereira S; Woloszynek J; Lowell CA; Link DC
    Blood; 2006 Oct; 108(8):2562-8. PubMed ID: 16772601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Socs3 maintains the specificity of biological responses to cytokine signals during granulocyte and macrophage differentiation.
    Croker BA; Mielke LA; Wormald S; Metcalf D; Kiu H; Alexander WS; Hilton DJ; Roberts AW
    Exp Hematol; 2008 Jul; 36(7):786-98. PubMed ID: 18400361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling.
    van de Geijn GJ; Gits J; Touw IP
    J Leukoc Biol; 2004 Jul; 76(1):237-44. PubMed ID: 15107455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT3 controls myeloid progenitor growth during emergency granulopoiesis.
    Zhang H; Nguyen-Jackson H; Panopoulos AD; Li HS; Murray PJ; Watowich SS
    Blood; 2010 Oct; 116(14):2462-71. PubMed ID: 20581311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine-dependent and -independent mechanisms of STAT3 activation by the human granulocyte colony-stimulating factor (G-CSF) receptor are differentially utilized depending on G-CSF concentration.
    Ward AC; Hermans MH; Smith L; van Aesch YM; Schelen AM; Antonissen C; Touw IP
    Blood; 1999 Jan; 93(1):113-24. PubMed ID: 9864153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G-CSF maintains controlled neutrophil mobilization during acute inflammation by negatively regulating CXCR2 signaling.
    Bajrami B; Zhu H; Kwak HJ; Mondal S; Hou Q; Geng G; Karatepe K; Zhang YC; Nombela-Arrieta C; Park SY; Loison F; Sakai J; Xu Y; Silberstein LE; Luo HR
    J Exp Med; 2016 Sep; 213(10):1999-2018. PubMed ID: 27551153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transcription factor Gfi1 regulates G-CSF signaling and neutrophil development through the Ras activator RasGRP1.
    de la Luz Sierra M; Sakakibara S; Gasperini P; Salvucci O; Jiang K; McCormick PJ; Segarra M; Stone J; Maric D; Zhu J; Qian X; Lowy DR; Tosato G
    Blood; 2010 May; 115(19):3970-9. PubMed ID: 20203268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SOCS box of suppressor of cytokine signaling-3 contributes to the control of G-CSF responsiveness in vivo.
    Boyle K; Egan P; Rakar S; Willson TA; Wicks IP; Metcalf D; Hilton DJ; Nicola NA; Alexander WS; Roberts AW; Robb L
    Blood; 2007 Sep; 110(5):1466-74. PubMed ID: 17510322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of CCR2, flotillin, and gp49B genes as new G-CSF targets during neutrophilic differentiation.
    Iida S; Kohro T; Kodama T; Nagata S; Fukunaga R
    J Leukoc Biol; 2005 Aug; 78(2):481-90. PubMed ID: 15894583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G-CSF-activated STAT3 enhances production of the chemokine MIP-2 in bone marrow neutrophils.
    Nguyen-Jackson HT; Li HS; Zhang H; Ohashi E; Watowich SS
    J Leukoc Biol; 2012 Dec; 92(6):1215-25. PubMed ID: 23024284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis.
    Croker BA; Metcalf D; Robb L; Wei W; Mifsud S; DiRago L; Cluse LA; Sutherland KD; Hartley L; Williams E; Zhang JG; Hilton DJ; Nicola NA; Alexander WS; Roberts AW
    Immunity; 2004 Feb; 20(2):153-65. PubMed ID: 14975238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia.
    Lee J; Kim Y; Lim J; Kim M; Han K
    Ann Clin Lab Sci; 2008; 38(4):331-7. PubMed ID: 18988925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of Socs3 leads to brain-targeted EAE via enhanced neutrophil activation and ROS production.
    Yan Z; Yang W; Parkitny L; Gibson SA; Lee KS; Collins F; Deshane JS; Cheng W; Weinmann AS; Wei H; Qin H; Benveniste EN
    JCI Insight; 2019 Apr; 5(9):. PubMed ID: 30939124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of Stat3 and ERK in G-CSF signaling.
    Kamezaki K; Shimoda K; Numata A; Haro T; Kakumitsu H; Yoshie M; Yamamoto M; Takeda K; Matsuda T; Akira S; Ogawa K; Harada M
    Stem Cells; 2005 Feb; 23(2):252-63. PubMed ID: 15671148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.